So they were, they were asking for money, for funding, for like a phase three drug trial for a oral, I think it was an IL 17 blocker
plantarum and Pediococcus acidilactici for 30-days, showed total remission of 53.1% in the probiotic-treated compared to 28.1% in the placebo groups, respectively
Again, these peptides are not FDA-approved and fall under Category 2, meaning they are legally limited to research settings and are not officially sanctioned for medical treatment
Here's what actually happens: BPC-157 and TB-500: Structural tissue repair is permanent new collagen and remodeled disc tissue doesn't un-heal when you stop the peptides
These beneficial effects manifested with altered gene expression, including genes that increased ( Egr, Nos3, Srf, and Kras ) and genes that decreased ( Egr1, Vegfr2, and Plc ), while Akt1 remained unchanged in the inferior caval vein, the right ovarian vein and the left ovarian vein (Vukojevic et al., 2018)